Cavitation Technologies signs $35 million cash tender offer deal with BrightFlixx Finance Luxembourg

BrightFlixx Finance (Luxembourg) signed definitive purchase agreements for all outstanding shares of Cavitation Technologies’ common stock. Aggregate proposed cash consideration totals USD 42 million, including USD 35 million for Cavitation Technologies. Agreements also cover Alchemy Beverages, with USD 7 million of the proposed consideration allocated to Alchemy. New agreements replace prior tender offer arrangements with European Guarantee Services, which were terminated. Financing remains backed by Bright Wealth Banking, the same institution involved in the earlier transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cavitation Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-007778), on October 13, 2026, and is solely responsible f